datamatters24/research-document-archive huggingface dataset:
I 
118TH CONGRESS 
1ST SESSION 
H. R. 39 
To amend title 38, United States Code, to direct the Secretary of Veterans 
Affairs to establish the Merchant Mariner Equity Compensation Fund 
to provide benefits to certain individuals who served in the United States 
merchant marine (including the Army Transport Service and the Naval 
Transport Service) during World War II. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 9, 2023 
Mr. GREEN of Texas introduced the following bill; which was referred to the 
Committee on Veterans’ Affairs 
A BILL 
To amend title 38, United States Code, to direct the Sec-
retary of Veterans Affairs to establish the Merchant 
Mariner Equity Compensation Fund to provide benefits 
to certain individuals who served in the United States 
merchant marine (including the Army Transport Service 
and the Naval Transport Service) during World War 
II. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Honoring Our WWII 
Merchant Mariners Act of 2023’’. 
VerDate Sep 11 2014 
03:50 Jan 12, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H39.IH
H39
kjohnson on DSK79L0C42PROD with BILLS
A BILL 
To amend the Save Our Seas 2.0 Act to make the District 
of Columbia eligible for certain wastewater infrastructure 
grants, and for other purposes. 
VerDate Sep 11 2014 
19:21 Dec 19, 2024
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6652
E:\BILLS\H4043.RH
H4043
ssavage on LAPJG3WLY3PROD with BILLS
I 
118TH CONGRESS 
1ST SESSION H. R. 4000 
To authorize States to bring civil actions against the Government of the 
People’s Republic of China for harm suffered by the State as a result 
of the COVID–19 pandemic. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 12, 2023 
Mr. SANTOS introduced the following bill; which was referred to the 
Committee on the Judiciary 
A BILL 
To authorize States to bring civil actions against the Govern-
ment of the People’s Republic of China for harm suffered 
by the State as a result of the COVID–19 pandemic. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘CCP Virus Reimburse-
ment For States Act of 2023’’. 
SEC. 2. CIVIL ACTION AUTHORIZED FOR STATES RELATED 
TO COVID–19 HARM. 
(a) IN GENERAL.—Notwithstanding any other provi-
sion of law (including chapter 85 of title 28, United States 
VerDate Sep 11 2014 
03:42 Jul 11, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4000.IH
H4000
pbinns on DSKJLVW7X2PROD with $$_JOB
Medicine shall submit to Committee on Science, 
Space, and Technology, the Committee on Education 
and the Workforce, and the Committee on Energy 
and Commerce of the House of Representatives and 
the Committee on Commerce, Science, and Trans-
portation and the Committee on Health, Education, 
Labor, and Pensions of the Senate a report con-
taining the results of the assessment under such 
paragraph and recommendations relating thereto re-
garding how Federal agencies, Congress, institutions 
of higher education, and other relevant entities may 
address financial instability of graduate researchers 
and postdoctoral researchers. 
(f) GAO STUDY.—Not later than three years after 
the date of the enactment of this Act, the Comptroller 
General of the United States shall submit to the Com-
mittee on Science, Space, and Technology, the Committee 
on Education and the Workforce, and the Committee on 
Energy and Commerce of the House of Representatives 
and the Committee on Commerce, Science, and Transpor-
tation and the Committee on Health, Education, Labor, 
and Pensions of the Senate a report that— 
(1) assesses the degree to which Federal re-
search agencies have implemented the policy guide-
VerDate Sep 11 2014 
02:29 Jul 11, 2023
Jkt 039200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H4002.IH
H4002
pbinns on DSKJLVW7X2PROD with $$_JOB
Code, commonly referred to as the ‘‘Foreign Sovereign Im-
munities Act’’) a State may bring an action for damages 
in an appropriate district court of the United States 
against the Government of the People’s Republic of China 
for harm suffered by the State as a result of the COVID– 
19 pandemic. 
(b) PAYMENT BY UNITED STATES.—If a State is 
awarded damages in an action under this section, and the 
Government of the People’s Republic of China has not sat-
isfied such award before the date that is one year after 
the date on which the damages were awarded, the State 
may seek an order from the court directing the United 
States to pay such award to the State. The payment by 
the United States of any such award shall be deducted 
from any interest or debt owed by the United States to 
the People’s Republic of China, or from any amounts 
made available to provide United States assistance to the 
People’s Republic of China. 
(c) DEFINITION.—In this section, the term ‘‘harm’’ 
includes costs associated with— 
(1) the payment of overtime to frontline work-
ers; 
(2) purchasing masks and sanitizing products; 
(3) purchasing vaccines; 
(4) research and development; 
VerDate Sep 11 2014 
03:42 Jul 11, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4000.IH
H4000
pbinns on DSKJLVW7X2PROD with $$_JOB
(5) developing COVID–19 testing sites and 
testing individuals for COVID–19; 
(6) purchasing medical equipment related to 
COVID–19; 
(7) unemployment payments; and 
(8) laws to provide other assistance during the 
COVID–19 pandemic. 
Æ 
VerDate Sep 11 2014 
03:42 Jul 11, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\H4000.IH
H4000
pbinns on DSKJLVW7X2PROD with $$_JOB
I 
118TH CONGRESS 
1ST SESSION H. R. 4001 
To prohibit arms sales, cybersecurity sales, and military sales with the 
People’s Republic of China and the Chinese Communist Party. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 12, 2023 
Mr. SANTOS introduced the following bill; which was referred to the 
Committee on Foreign Affairs 
A BILL 
To prohibit arms sales, cybersecurity sales, and military sales 
with the People’s Republic of China and the Chinese 
Communist Party. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. PROHIBITION ON ARMS SALES, CYBERSECU-
RITY SALES, AND MILITARY SALES WITH THE 
PEOPLE’S REPUBLIC OF CHINA AND THE CHI-
NESE COMMUNIST PARTY. 
No arms sales, cybersecurity sales, or military sales 
may be entered into with the People’s Republic of China 
or the Chinese Communist Party by— 
(1) the United States Government; or 
VerDate Sep 11 2014 
21:49 Jul 12, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4001.IH
H4001
pbinns on DSKJLVW7X2PROD with $$_JOB
(2) any person using funds received under a 
contract or other agreement from the United States 
Government. 
Æ 
VerDate Sep 11 2014 
21:49 Jul 12, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H4001.IH
H4001
pbinns on DSKJLVW7X2PROD with $$_JOB
I 
118TH CONGRESS 
1ST SESSION H. R. 4002 
To require the Director of the Office of Science and Technology Policy 
to develop a consistent set of policy guidelines for Federal research 
agencies to address financial instability of graduate researchers and 
postdoctoral researchers, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 12, 2023 
Mrs. MCCLELLAN (for herself, Ms. TLAIB, Mr. KILMER, Ms. LEE of Pennsyl-
vania, Ms. TOKUDA, Ms. MCCOLLUM, Ms. CARAVEO, Mr. SARBANES, Mr. 
GREEN of Texas, and Mr. GRIJALVA) introduced the following bill; which 
was referred to the Committee on Science, Space, and Technology 
A BILL 
To require the Director of the Office of Science and Tech-
nology Policy to develop a consistent set of policy guide-
lines for Federal research agencies to address financial 
instability of graduate researchers and postdoctoral re-
searchers, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Relieving Economic 
Strain to Enhance American Resilience and Competitive-
VerDate Sep 11 2014 
22:22 Jul 10, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4002.IH
H4002
pbinns on DSKJLVW7X2PROD with $$_JOB
ness in Higher Education and Research Act’’ or the ‘‘RE-
SEARCHER Act’’. 
SEC. 2. POLICY GUIDELINES FOR FEDERAL RESEARCH 
AGENCIES TO ADDRESS FINANCIAL INSTA-
BILITY OF GRADUATE RESEARCHERS AND 
POSTDOCTORAL RESEARCHERS. 
(a) DEFINITION.—In this section: 
(1) INSTITUTION OF HIGHER EDUCATION.—The 
term ‘‘institution of higher education’’ has the 
meaning given such term in section 101 of the High-
er Education Act of 1965 (20 U.S.C. 1001). 
(2) 
GRADUATE
RESEARCHERS.—The 
term 
‘‘graduate researchers’’ means individuals enrolled in 
a degree program leading to an advanced degree who 
receive stipends or other compensation to conduct 
research in any discipline at an institution of higher 
education that is a recipient of Federal funding. 
(3) POSTDOCTORAL RESEARCHERS.—The term 
‘‘postdoctoral researchers’’ means individuals in 
training-focused positions who have received a doc-
toral degree or equivalent and receive stipends or 
other compensation to conduct research in any dis-
cipline at an institution of higher education that is 
a recipient of Federal funding. 
(b) OSTP GUIDELINES.— 
VerDate Sep 11 2014 
22:22 Jul 10, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4002.IH
H4002
pbinns on DSKJLVW7X2PROD with $$_JOB
573 
(119) Heading 9902.03.74 (relating to 2,4-xyli-
dine). 
(120) Heading 9902.03.75 (relating to mixed 
xylidines). 
(121) Heading 9902.03.76 (relating to dodecyl 
aniline mixed isomers). 
(122) Heading 9902.03.78 (relating to amino 
methyl benzene). 
(123) Heading 9902.03.79 (relating to 2-ethyl- 
6-methylaniline). 
(124) 
Heading 
9902.03.90 
(relating 
to 
dipropoxy-p-toluidine). 
(125) Heading 9902.03.95 (relating to RODA). 
(126) Heading 9902.03.96 (relating to 4- 
methoxy-2-methyldiphenylamine). 
(127) Heading 9902.04.04 (relating to 4- 
chlorophenylglycine). 
(128) Heading 9902.04.05 (relating to 2- 
amino-5-sulfobenzoic acid). 
(129) Heading 9902.04.09 (relating to inter-
mediate used in herbicides). 
(130) Heading 9902.04.10 (relating to man-
ganese disodium EDTA). 
(131) Heading 9902.04.11 (relating to sar-
cosine, sodium salt). 
VerDate Sep 11 2014 
01:14 Aug 26, 2023
Jkt 039200
PO 00000
Frm 00573
Fmt 6652
Sfmt 6201
E:\BILLS\H4276.IH
H4276
pbinns on DSKJLVW7X2PROD with $$_JOB
‘‘(A) FILING OF NOTIFICATION.—An appli-
cant for any next-generation hydropower project 
shall commence the licensing process by filing a 
notification of intent with the Commission. 
‘‘(B) DEADLINE
FOR
FILING.—Notwith-
standing section 15(b)(1), an applicant for a 
next-generation hydropower project shall file a 
notification of intent at least 2 years before the 
expiration of the existing license, if applicable. 
‘‘(2) FILING OF APPLICATION.— 
‘‘(A) GENERAL DEADLINE.—An applicant 
for a next-generation hydropower project shall 
submit to the Commission an application not 
later than 1 year after filing the notification of 
intent under paragraph (1). 
‘‘(B) EXISTING
LICENCEE
DEADLINE.— 
Notwithstanding section 15(c)(1), an applica-
tion for any next-generation hydropower project 
shall be filed with the Commission at least 1 
year before the expiration of the term of the ex-
isting license, if applicable. 
‘‘(3) DEADLINE FOR ISSUANCE.—The Commis-
sion shall take final action on a license for a next- 
generation hydropower project under this section not 
later than 2 years after the applicant notifies the 
VerDate Sep 11 2014 
23:49 Jul 12, 2023
Jkt 039200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H4045.IH
H4045
pbinns on DSKJLVW7X2PROD with $$_JOB
‘‘(ii) is located in an unfenced side or 
rear yard and is visible from an adjoining 
property. 
‘‘(2) REASONABLE APPLICATION AND ENFORCE-
MENT.—A private land use restriction permitted by 
paragraph (1) shall be reasonably applied and en-
forced. 
‘‘(c) LIMITATIONS ON PRIOR APPROVAL.— 
‘‘(1) REQUIREMENT
NOT
PRESENT
IN
LAND 
RECORDS AT TIME OF PURCHASE OR LEASE.—A re-
quirement in a private land use restriction for an 
amateur operator to obtain prior approval for the in-
stallation of an amateur station antenna may not be 
adopted or enforced if such requirement for prior 
approval was not present in the publicly recorded 
land records prior to the purchase or lease of the 
property by the amateur operator. 
‘‘(2) INFORMATION REQUIRED FOR PRIOR AP-
PROVAL.—A private land use restriction that re-
quires an amateur operator to submit an application 
for approval of an amateur station antenna prior to 
installation may not be adopted or enforced if the in-
formation required to be submitted as part of the 
application is greater or more detailed than the in-
VerDate Sep 11 2014 
22:23 Jul 10, 2023
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4006.IH
H4006
pbinns on DSKJLVW7X2PROD with $$_JOB
(1) shall have any cause of action or defense 
under the Agreement or by virtue of congressional 
approval thereof; or 
(2) may challenge, in any action brought under 
any provision of law, any action or inaction by any 
department, agency, or other instrumentality of the 
United States, any State, or any political subdivision 
of a State, on the ground that such action or inac-
tion is inconsistent with the Agreement. 
Æ 
VerDate Sep 11 2014 
01:03 Jun 13, 2023
Jkt 039200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6301
E:\BILLS\H4004.IH
H4004
pbinns on DSKJLVW7X2PROD with $$_JOB
I 
118TH CONGRESS 
1ST SESSION H. R. 4009 
To establish emergency paid sick leave for individuals impacted by a public 
health emergency, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 12, 2023 
Ms. BARRAGA´N (for herself, Ms. TOKUDA, Mr. LYNCH, Mr. CARSON, and Ms. 
NORTON) introduced the following bill; which was referred to the Com-
mittee on Education and the Workforce, and in addition to the Commit-
tees on Oversight and Accountability, House Administration, the Judici-
ary, and Ways and Means, for a period to be subsequently determined 
by the Speaker, in each case for consideration of such provisions as fall 
within the jurisdiction of the committee concerned 
A BILL 
To establish emergency paid sick leave for individuals im-
pacted by a public health emergency, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Public Health Emer-
gency Response Act’’. 
SEC. 2. TABLE OF CONTENTS. 
The table of contents for this Act is as follows: 
VerDate Sep 11 2014 
04:29 Jul 11, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4009.IH
H4009
pbinns on DSKJLVW7X2PROD with $$_JOB
paragraph that such pharmacy will not dispense 
such oral medication to such participant, bene-
ficiary, or enrollee by the 72-hour deadline de-
scribed in such subparagraph (or in the case 
that the participant, beneficiary, or enrollee has 
not received the oral medication by the 72-hour 
deadline), the plan or issuer— 
‘‘(i) shall authorize such participant, 
beneficiary, or enrollee to select any pro-
vider or pharmacy described in subpara-
graph (C) to dispense such oral medication 
to such participant, beneficiary, or enrollee 
based on the written notice described in 
paragraph (2)(C) or a certification by a 
the prescribing physician or other health 
professional that the participant, bene-
ficiary, or enrollee has not received the oral 
medication by the 72-hour deadline; and 
‘‘(ii) in the case that the provider or 
pharmacy selected under clause (i) does 
not have a contract with such plan or 
issuer to dispense such oral medication to 
such participant, group health plan or a 
health insurance issuer offering group or 
individual health insurance coverage de-
VerDate Sep 11 2014 
01:05 Jul 12, 2023
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H4011.IH
H4011
kjohnson on DSK79L0C42PROD with BILLS
574 
(132) Heading 9902.04.12 (relating to copper 
disodium EDTA). 
(133) Heading 9902.04.13 (relating to sodium 
lauriminodipropinonate). 
(134) Heading 9902.04.18 (relating to lecithin 
derived from sunflower). 
(135) Heading 9902.04.19 (relating to lecithin 
derived from soybeans). 
(136) Heading 9902.04.24 (relating to tetra-n- 
butylurea). 
(137) Heading 9902.04.26 (relating to certain 
crosslinking agent for powder coatings). 
(138) 
Heading 
9902.04.31 
(relating 
to 
Linuron). 
(139) 
Heading 
9902.04.32 
(relating 
to 
carboxyamide function compounds). 
(140) 
Heading 
9902.04.33 
(relating 
to 
Chlorpropham). 
(141) 
Heading 
9902.04.37 
(relating 
to 
Zoxamide). 
(142) 
Heading 
9902.04.40 
(relating 
to 
Flutolanil). 
(143) 
Heading 
9902.04.41 
(relating 
to 
Cyclanilide). 
VerDate Sep 11 2014 
01:14 Aug 26, 2023
Jkt 039200
PO 00000
Frm 00574
Fmt 6652
Sfmt 6201
E:\BILLS\H4276.IH
H4276
pbinns on DSKJLVW7X2PROD with $$_JOB
575 
(144) 
Heading 
9902.04.44 
(relating 
to 
Napropamide). 
(145) 
Holding 
9902.04.47 
(relating 
to 
Mandestrobin technical). 
(146) 
Heading 
9902.04.50 
(relating 
to 
MMTDCA). 
(147) Heading 9902.04.53 (relating to 2- 
chloroacetoacetanilide (AAOCA)). 
(148) 
Heading 
9902.04.54 
(relating 
to 
acetoacetyl-2,5-dimethoxy-4-chloroanilide). 
(149) 
Heading 
9902.04.72 
(relating 
to 
Cyfluthrin (excluding β-Cyfluthrin)). 
(150) 
Heading 
9902.04.73 
(relating 
to 
Cypermethrin). 
(151) Heading 9902.04.75 (relating to Alpha- 
Cypermethrin technical). 
(152) 
Heading 
9902.04.83 
(relating 
to 
aminoazobenzene-p-sulfonic acid). 
(153) 
Heading 
9902.04.91 
(relating 
to 
Daminozide). 
(154) 
Heading 
9902.04.92 
(relating 
to 
aminoguanidine bicarbonate). 
(155) Heading 9902.04.95 (relating to p- 
chlorophenylisocyanate). 
VerDate Sep 11 2014 
01:14 Aug 26, 2023
Jkt 039200
PO 00000
Frm 00575
Fmt 6652
Sfmt 6201
E:\BILLS\H4276.IH
H4276
pbinns on DSKJLVW7X2PROD with $$_JOB
scribed in paragraph (1) shall cover the 
medication and pay the provider or phar-
macy in accordance with the provisions of 
subparagraph (B). 
‘‘(B) COVERAGE REQUIREMENTS FOR PRE-
SCRIPTIONS
DISPENSED
BY
ALTERNATE
PRO-
VIDER OR PHARMACY.—For prescriptions dis-
pensed by an alternate provider or pharmacy in 
accordance with subparagraph (A) that does 
not have a contract with a group health plan or 
a health insurance issuer offering group or indi-
vidual health insurance coverage (or its agent, 
including a pharmacy benefits manager) de-
scribed in paragraph (1) to dispense such oral 
medication to such participant, such group 
health plan or a health insurance issuer (or its 
agent, including a pharmacy benefits manager) 
shall cover the medication and pay the provider 
or pharmacy subject to the following require-
ments— 
‘‘(i) such medication will be provided 
without imposing any requirement under 
the plan for prior authorization of the 
medication or any limitation on coverage 
that is more restrictive than the require-
VerDate Sep 11 2014 
01:05 Jul 12, 2023
Jkt 039200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H4011.IH
H4011
kjohnson on DSK79L0C42PROD with BILLS
ments or limitations that apply to oral 
medications received from participating 
providers and pharmacies with respect to 
such plan; 
‘‘(ii) the cost-sharing requirement (ex-
pressed as a copayment amount or coinsur-
ance rate) is not greater than the require-
ment that would apply if such services 
were provided by a participating provider 
or a participating pharmacy; 
‘‘(iii) such cost-sharing requirement is 
calculated as if the total amount that 
would have been charged for such services 
by such participating provider or partici-
pating pharmacy were equal to the recog-
nized amount (as determined by the Sec-
retary) for such oral medications, plan, 
and year; 
‘‘(iv) the group health plan pays to 
such provider or pharmacy, respectively, 
the amount by which the recognized 
amount for such services and year involved 
exceeds the cost-sharing amount for such 
services (as determined in accordance with 
clauses (ii) and (iii)) and year; 
VerDate Sep 11 2014 
01:05 Jul 12, 2023
Jkt 039200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H4011.IH
H4011
kjohnson on DSK79L0C42PROD with BILLS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Investing in Main 
Street Act of 2023’’. 
SEC. 2. INVESTMENT IN SMALL BUSINESS INVESTMENT 
COMPANIES. 
Section 302(b) of the Small Business Investment Act 
of 1958 (15 U.S.C. 682(b)) is amended— 
(1) in paragraph (1), by striking ‘‘5 percent’’ 
and inserting ‘‘15 percent’’; and 
(2) in paragraph (2), by striking ‘‘5 percent’’ 
and inserting ‘‘15 percent’’. 
Passed the House of Representatives January 25, 
2023. 
Attest: 
Clerk.
118TH CONGRESS 
1ST SESSION 
H. R. 400 
AN ACT 
To amend the Small Business Investment Act of 
1958 to increase the amount that may be in-
vested in small business investment companies.
I 
118TH CONGRESS 
1ST SESSION 
H. R. 400 
To amend the Small Business Investment Act of 1958 to increase the amount 
that may be invested in small business investment companies. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 20, 2023 
Ms. CHU (for herself and Mr. GARBARINO) introduced the following bill; which 
was referred to the Committee on Small Business 
A BILL 
To amend the Small Business Investment Act of 1958 to 
increase the amount that may be invested in small busi-
ness investment companies. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Investing in Main 
Street Act of 2023’’. 
SEC. 2. INVESTMENT IN SMALL BUSINESS INVESTMENT 
COMPANIES. 
Section 302(b) of the Small Business Investment Act 
of 1958 (15 U.S.C. 682(b)) is amended— 
VerDate Sep 11 2014 
01:07 Jan 21, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H400.IH
H400
pbinns on DSKJLVW7X2PROD with $$_JOB
(1) in paragraph (1), by striking ‘‘5 percent’’ 
and inserting ‘‘15 percent’’; and 
(2) in paragraph (2), by striking ‘‘5 percent’’ 
and inserting ‘‘15 percent’’. 
Æ 
VerDate Sep 11 2014 
01:07 Jan 21, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H400.IH
H400
pbinns on DSKJLVW7X2PROD with $$_JOB
(C) does not include the practice of rearing 
and releasing cultured species for the purpose 
of enhancing wild populations. 
(2) AQUACULTURE STAKEHOLDER.—The term 
‘‘aquaculture stakeholder’’ means owners and opera-
tors of offshore aquaculture facilities, Regional Fish-
ery Management Councils, interstate fisheries com-
missions, conservation organizations, fisheries asso-
ciations, State, county, and federally recognized In-
dian Tribes, and other interested parties. The term 
also includes other Federal agencies that have inter-
ests in aquaculture. 
(3) COASTAL STATE.—Except as otherwise spe-
cifically provided, the term ‘‘coastal State’’ has the 
meaning given the term ‘‘coastal state’’ in section 
304(4) of the Coastal Zone Management Act of 
1972 (16 U.S.C. 1453(4)). 
(4) CULTURED SPECIES.—The term ‘‘cultured 
species’’ means any species propagated and reared 
for marine aquaculture. The term includes larval 
marine shellfish species that self-recruit in the off-
shore environment. The term excludes any member 
of the class aves, reptilia, or mammalia. 
(5) EXCLUSIVE ECONOMIC ZONE.— 
VerDate Sep 11 2014 
04:36 Jun 30, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4013.IH
H4013
kjohnson on DSK79L0C42PROD with BILLS
(B) an assessment of the effects on patient 
health outcomes, including morbidity and mor-
tality; 
(C) an evaluation of costs to patients, 
health insurance issuers, physicians, and other 
healthcare providers; and 
(D) a risk assessment with mitigation rec-
ommendations on any actual or potential fraud, 
waste and abuse relating to the implementation 
of such subsection. 
(d) EFFECTIVE DATE.—The amendments made by 
this section shall apply with respect to plan years begin-
ning on or after January 1, 2024. 
Æ 
VerDate Sep 11 2014 
01:05 Jul 12, 2023
Jkt 039200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6301
E:\BILLS\H4011.IH
H4011
kjohnson on DSK79L0C42PROD with BILLS